Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharma save search
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
COCP | $1.43 -1.39% 5.1K
|
Health Technology
|
| O: 2.68%
H: 13.73%
C: -8.5%
pharma antiviral financial results
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Published: 2024-03-26 (Crawled : 21:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
Published: 2024-03-26 (Crawled : 21:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma employee
MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia
Published: 2024-03-26 (Crawled : 19:00) - biospace.com/
MEIP | $3.38 2.11% 2.07% 12K
|
Health Technology
|
| O: -1.08%
H: 1.9%
C: 0.78%
pharma update leukemia study
Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024
Published: 2024-03-26 (Crawled : 12:30) - globenewswire.com
INZY | $4.57 -1.72% -1.75% 560K
|
Health Technology
|
| O: 2.09%
H: 14.47%
C: 6.6%
inz-701 pharma report ongoing trials topline
Global Transdermal Medical Patch Market Analysis 2024-2029, Featuring Novartis, Viatris, Nitto Denko, Luye Pharma, Hisamitsu Pharmaceutical, Medline Industries, Corium, UCB, Teikoku Pharma and More
Published: 2024-03-25 (Crawled : 00:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
pharma transdermal global medical market
NewAmsterdam Pharma to Present New Analysis from the Phase 2 ROSE2 Trial Evaluating Obicetrapib in Combination with Ezetimibe at 2024 American College of Cardiology Congress
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
NAMS | $19.415 -3.17% -3.27% 220K
|
n/a
|
| O: -1.03%
H: 2.61%
C: 1.91%
pharma congress trial cardiology
Nutra Pharma Corp. Reaches Settlement with SEC
Published: 2024-03-22 (Crawled : 21:00) - globenewswire.com
NPHC | $0.0001 2900.0% 3
|
Manufacturing
| Email alert
Add to watchlist
MEDE | News | $0.51 0% 500
|
n/a
| Email alert
Add to watchlist
pharma
Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update
Published: 2024-03-22 (Crawled : 13:00) - prnewswire.com
SHPH | $0.4099 -2.69% 11K
|
|
| O: -0.44%
H: 2.0%
C: -0.44%
pharma update
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Published: 2024-03-22 (Crawled : 11:00) - globenewswire.com
HOOK | $0.7695 0.92% 0.91% 170K
|
Health Technology
|
| O: 3.58%
H: 0.0%
C: -5.19%
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 0.03%
H: 0.16%
C: -0.68%
pharma business year financial results
Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive Officer
Published: 2024-03-21 (Crawled : 20:00) - globenewswire.com
EVOK | $0.489 -10.93% -12.27% 21K
|
Health Technology
|
| O: 0.83%
H: 4.45%
C: 1.19%
pharma
Zealand Pharma major shareholder announcement: Van Herk Investments
Published: 2024-03-21 (Crawled : 17:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma investments
Innate Pharma Reports Full Year 2023 Financial Results and Business Update
Published: 2024-03-21 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -4.51%
H: 4.25%
C: 0.96%
pharma business year update financial results
Silo Pharma Exercises Option for Exclusive License Agreement for First-in-Class PTSD and Stress-Induced Anxiety Therapeutic
Published: 2024-03-20 (Crawled : 12:30) - globenewswire.com
SILO | $1.96 1.02% 6.6K
|
Finance and Insurance
|
| O: 1.14%
H: 2.26%
C: 2.26%
pharma license agreement
Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042
Published: 2024-03-20 (Crawled : 12:00) - globenewswire.com
LUMO | News | $2.64 4.76% 4.55% 12K
|
Health Technology
|
| O: -4.7%
H: 12.62%
C: 12.62%
lum-201 pharma patent granted
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - March 20, 2024
Published: 2024-03-20 (Crawled : 12:00) - biospace.com/
BBIO | $24.98 0.0% 2M
|
Health Technology
|
| O: 0.46%
H: 1.37%
C: 0.25%
pharma nasdaq grants
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-20 (Crawled : 12:00) - bridgebio.com
BBIO | $24.98 0.0% 2M
|
Health Technology
|
| O: 0.46%
H: 1.37%
C: 0.25%
pharma nasdaq grants
Parenteral Nutrition Market Global Analysis and Forecasts to 2030, Featuring Fresenius Kabi, Grifols, Pfizer, Otsuka Pharmaceutical, Baxter, Sichuan Kelun Pharmaceutical, Vifor Pharma and Aculife
Published: 2024-03-19 (Crawled : 23:00) - prnewswire.com
GRFS | News | $6.53 -0.76% -0.77% 760K
|
Health Technology
|
| O: 1.49%
H: 2.76%
C: 2.28%
pharma nutrition global market
Zealand Pharma major shareholder announcement: Polar Capital
Published: 2024-03-19 (Crawled : 16:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Published: 2024-03-19 (Crawled : 16:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.